Euro-BioImaging (EuBI) is an extensive research infrastructure that provides open access, services and training to a broad range of state-of-the-art biological and medical imaging technologies. EuBI offers validated, high quality services to life scientists in Europe and beyond, in a coordinated and harmonized environment, hosted by top research institutes across Europe.
EuBI now invites scientists to submit their online applications for access to one of the 29 EuBI Node Candidates, all of which offer cutting-edge imaging technologies and expertise to make your research project a big success!
This Interim Web Access Portal is the virtual entry point to access EuBI services during the current Interim Operation period. Both EuBI services and this portal are not yet operating at their full potential, and not all functionality is included yet. EuBI and this portal will evolve into full-fledged versions after EuBI is officially launched as an ERIC (European Research Infrastructure Consortium), foreseen to take place in early 2019.
EuBI now invites scientists to submit their online applications for access to one of the 29 EuBI Node Candidates, all of which offer cutting-edge imaging technologies and expertise to make your research project a big success!
This Interim Web Access Portal is the virtual entry point to access EuBI services during the current Interim Operation period. Both EuBI services and this portal are not yet operating at their full potential, and not all functionality is included yet. EuBI and this portal will evolve into full-fledged versions after EuBI is officially launched as an ERIC (European Research Infrastructure Consortium), foreseen to take place in early 2019.
The Euro-BioImaging Interim Web Access Portal and the related Euro-BioImaging database, with the user information processed and contained within, are fully committed to be operated according to the EU’s General Data Protection Regulation (GDPR). A full GDPR declaration has been written and will become available on the Interim Web Access Portal in the near future. For additional information, please contact [email protected].